Papers
18
Total Citations
870
H-Index
13
About
Hartwig Huland is a pioneering urological surgeon and researcher whose work has profoundly shaped the field of prostate cancer surgery, particularly through innovations in radical prostatectomy techniques. Based at the Martini Clinic Prostate Cancer Center in Hamburg, Huland has dedicated his career to improving oncological and functional outcomes for men undergoing surgical prostate cancer treatment. His most celebrated contribution is the development and refinement of NeuroSAFE — Neurovascular Structure-adjacent Frozen-section Examination — a technique that dramatically increases nerve-sparing frequency while reducing positive surgical margins. His landmark 2012 paper documenting outcomes across 11,069 consecutive patients (280 citations) remains highly influential and catalyzed widespread adoption of the technique. He subsequently helped adapt NeuroSAFE for robot-assisted laparoscopic prostatectomy, bridging traditional and emerging surgical platforms. Huland has also produced rigorous large-scale comparative research analyzing open versus robotic prostatectomy across thousands of patients, examining complication profiles, continence, potency, and oncological control. His advocacy for centralization of complex surgical care in high-volume centers reflects a broader commitment to quality-driven healthcare systems. With a career spanning extraordinary patient volumes and groundbreaking technical innovations, Huland stands as one of contemporary urology's most consequential figures.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10